Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-1730

2 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-1730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 1730 3 C98)

Pdp (68071 1730 3 C98)
The label is for Ondansetron ODT 8 mg orally disintegrating tablets, packaged in a count of 30, supplied by NuCare Pharmaceuticals, Inc. It includes NDC 68071-1730-3 and indicates prescription use only. The label advises seeing the manufacturer’s label for a full list of ingredients and includes warnings to keep out of reach of children and to store at controlled temperatures.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of the active ingredient Ondansetron, showing its molecular framework with distinct rings and functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.